Literature DB >> 21897579

Authors' reply.

Sanjay Rao1, Ashley L J D'Cruz.   

Abstract

Entities:  

Year:  2011        PMID: 21897579      PMCID: PMC3160058     

Source DB:  PubMed          Journal:  J Indian Assoc Pediatr Surg        ISSN: 0971-9261


× No keyword cloud information.
Sir, Thank you for the queries raised. Please find the clarifications below: Financial Cost of the treatment The cost of the transplantation procedure is packaged at INR 12 lakhs at our center. This includes both the donor, the recipient operations, and postoperative care until discharge. The major items of cost include disposables, medications, drugs used, and laboratory testing of tacrolimus levels. However, this amount varies widely across the country and is by no means the standard. Indirect costs are again very variable and depend entirely on the family's preferences and lifestyles. In the first year post transplant, the immunosuppression is higher and the tacrolimus testing frequent. The expense for the medications and tests range from INR 12000-15,000 per month in the first year. Subsequently, the costs come down and by the third year post transplant, it works out to about INR 4000 per month. Fortunately, as transplantation becomes more mainstream, the costs — both of the medication and the testing, have been steadily falling. Survival by etiology This data needs to be qualified by the following facts: Children with biliary atresia are often in poor health. A combination of poor nutritional status, previous abdominal surgery, cholangitis, portal hypertension, and often spontaneous bacterial peritonitis puts these children in a very high-risk category. In this series, most of the deaths happened early in the series; most early cases performed were biliary atresia children, who had had a Kasai procedure by the same team earlier. This is reflected in the fairly high mortality in this group. Of the cases operated later in the series, survivals for biliary atresia have been on par with other indications. There has been only one child in each of the last four4 groups. Although the only child with fulminant hepatic failure in this series survived, he has residual neurological sequelae. The published literature suggests a survival rate of >70% for acute liver transplantation in fulminant hepatic failure as compared to >90% for other indications.[1] Indian Experience of Liver Transplantation Unfortunately the published Indian experience is scanty and mostly restricted to case reports and short communications.[23] In the major centers, about 10% of the patients undergoing liver transplantation are children. The number of small children (<10 kg) undergoing transplants are even less (personal communication).
  3 in total

1.  India's first successful pediatric liver transplant.

Authors:  P Poonacha; A Sibal; A S Soin; M R Rajashekar; D V Rajakumari
Journal:  Indian Pediatr       Date:  2001-03       Impact factor: 1.411

2.  Liver transplantation in children.

Authors:  D A Kelly; Anupam Sibal
Journal:  Indian Pediatr       Date:  2006-05       Impact factor: 1.411

3.  Outcome of live donor liver transplantation in Indian children with bodyweight <7.5 kg.

Authors:  Satvinder Kaur; Nishant Wadhwa; Anupam Sibal; Nameet Jerath; Shridhar Sasturkar
Journal:  Indian Pediatr       Date:  2011-08-01       Impact factor: 1.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.